Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: J Immunol. 2011 Oct 21;187(11):5756–5763. doi: 10.4049/jimmunol.1102133

FIGURE 1.

FIGURE 1

Study protocols. A: Protocol 1: Mice were exposed to 10 intranasal (I.N.) HDM doses over 24 days. Rapamycin treatment by intraperitoneal injection (I.P.) was started simultaneously with HDM exposure and continued 6 days per week until one day after the last HDM exposure for a total of 20 injections. B: Protocol 2: Mice were sensitized to HDM by 3 I.P. injections before I.N. challenge with saline or HDM. Rapamycin treatment was started after the last I.P. injection and one day prior to I.N. HDM exposure.